{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T08:10:02Z","timestamp":1756368602889,"version":"3.44.0"},"reference-count":11,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2018,11,25]]},"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:p>We present two cases of patient\u2019s with long-standing autoimmune diseases being treated with immunosuppressants that developed aggressive lymphoproliferative disorders. Immunosuppressants have a well-known association with disorders. Sustained regression of these lymphoproliferative disorders occurred with simple discontinuation of these immunosuppressive agents.<\/jats:p>","DOI":"10.1136\/bcr-2018-226545","type":"journal-article","created":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T17:19:47Z","timestamp":1545153587000},"page":"e226545","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Treatment of advanced stage methotrexate-associated lymphoproliferative disorders (MTX-LPDs) with methotrexate discontinuation"],"prefix":"10.1136","volume":"11","author":[{"given":"Yael","family":"Ross","sequence":"first","affiliation":[{"name":"GME Internal Medicine, WellStar Kennestone Hospital, Marietta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Kamran","sequence":"additional","affiliation":[{"name":"GME Internal Medicine, WellStar Kennestone Regional Medical Center, Marietta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,12,13]]},"reference":[{"key":"2025082800451692000_11.1.e226545.1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3960\/jslrt.52.193","article-title":"Successful treatment of immunodeficiency-associated EBV-negative lymphoproliferative disorders in rheumatoid arthritis by methotrexate withdrawal and prevention of its relapse by rituximab administration","volume":"52","author":"Kawano","year":"2012","journal-title":"J Clin Exp Hematop"},{"key":"2025082800451692000_11.1.e226545.2","first-page":"1","article-title":"Complete remission of methotrexate-related epstein-barr-virus-associated hodgkin-like lymphoma following withdrawal of mtx coupled with clarithromycin administration","volume":"2012","author":"Takemori","year":"2012","journal-title":"Case Rep Hematol"},{"key":"2025082800451692000_11.1.e226545.3","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.2169\/internalmedicine.54.4207","article-title":"Spontaneous regression of methotrexate-related lymphoproliferative disorder with t-cell large granular lymphocytosis","volume":"54","author":"Ureshino","year":"2015","journal-title":"Intern Med"},{"key":"2025082800451692000_11.1.e226545.4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12328-015-0624-5","article-title":"Methotrexate-related lymphoproliferative disorder of the stomach in a patient with rheumatoid arthritis: a case of disease regression after methotrexate cessation","volume":"9","author":"Ikeda","year":"2016","journal-title":"Clin J Gastroenterol"},{"key":"2025082800451692000_11.1.e226545.5","doi-asserted-by":"crossref","unstructured":"Kawahara A , Tsukada J , Yamaguchi T , et al . Reversible methotrexate-associated lymphoma of the liver in rheumatoid arthritis: a unique case of primary hepatic lymphoma. Biomarker Research [Internet]. 2015;3:10\u201315.","DOI":"10.1186\/s40364-015-0035-2"},{"key":"2025082800451692000_11.1.e226545.6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-008-9069-8","article-title":"Spontaneous remission of\u00a0\u201cmethotrexate-associated lymphoproliferative disorders\u201d after discontinuation of immunosuppressive treatment for autoimmune disease. Review of the literature","volume":"26","author":"Rizzi","year":"2009","journal-title":"Med Oncol"},{"key":"2025082800451692000_11.1.e226545.7","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.11.3909"},{"key":"2025082800451692000_11.1.e226545.8","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12116"},{"key":"2025082800451692000_11.1.e226545.9","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/cas.13249","article-title":"Clinicopathological analysis of methotrexate-associated lymphoproliferative disorders: Comparison of diffuse large B-cell lymphoma and classical Hodgkin lymphoma types","volume":"108","author":"Gion","year":"2017","journal-title":"Cancer Sci"},{"key":"2025082800451692000_11.1.e226545.10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3960\/jslrt.56.165","article-title":"The aggressive clinical courses of Hodgkin lymphoma primarily diagnosed as methotrexate-induced non-specific lymphoproliferative disorder in patients with rheumatoid arthritis","volume":"56","author":"Tokuhira","year":"2017","journal-title":"J Clin Exp Hematop"},{"key":"2025082800451692000_11.1.e226545.11","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1186\/s12885-016-2672-8","article-title":"The usefulness of (18)F-FDG PET\/CT for assessing methotrexate-associated lymphoproliferative disorder (MTX-LPD)","volume":"16","author":"Watanabe","year":"2016","journal-title":"BMC Cancer"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bcr-2018-226545","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2018-226545","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T07:45:27Z","timestamp":1756367127000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2018-226545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":11,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12,13]]},"published-print":{"date-parts":[[2018,11]]}},"alternative-id":["10.1136\/bcr-2018-226545"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2018-226545","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}